Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,512 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $552.37 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $240.79 | 14 | $0 (2024) |
| Abbott Laboratories | $141.97 | 1 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $125.00 | 1 | $0 (2024) |
| Alkermes, Inc. | $110.45 | 1 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $97.17 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $78.55 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $72.18 | 5 | $0 (2023) |
| PFIZER INC. | $65.33 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $14.88 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $701.60 | 11 | ABBVIE INC. ($142.93) |
| 2023 | $593.72 | 19 | ABBVIE INC. ($344.31) |
| 2022 | $70.82 | 5 | E.R. Squibb & Sons, L.L.C. ($55.74) |
| 2021 | $145.88 | 8 | Janssen Pharmaceuticals, Inc ($67.50) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $141.97 | General |
| Category: Structural Heart | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/31/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 05/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/07/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $97.17 | General |
| 02/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $110.45 | General |
| Category: CNS | ||||||
| 01/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/07/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 12/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $103.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 06/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Cardiovascular | ||||||
| 05/31/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/15/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 187 | 405 | $176,799 | $32,321 |
| 2022 | 3 | 158 | 408 | $134,005 | $25,449 |
| 2021 | 3 | 164 | 474 | $165,131 | $33,087 |
| 2020 | 6 | 200 | 338 | $183,942 | $24,637 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 234 | $115,758 | $20,702 | 17.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 113 | $32,455 | $6,648 | 20.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 55 | 58 | $28,586 | $4,971 | 17.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 68 | 193 | $72,447 | $13,599 | 18.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 59 | 180 | $47,803 | $9,197 | 19.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 31 | 35 | $13,755 | $2,654 | 19.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 84 | 309 | $117,703 | $23,612 | 20.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 52 | 137 | $36,431 | $7,223 | 19.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 28 | 28 | $10,997 | $2,253 | 20.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 42 | 114 | $37,152 | $9,035 | 24.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 61 | 120 | $27,664 | $6,557 | 23.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 34 | 37 | $65,009 | $4,404 | 6.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 27 | 30 | $35,820 | $2,502 | 7.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 19 | 19 | $6,957 | $1,554 | 22.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 17 | 18 | $11,340 | $584.65 | 5.2% |
About Dennis Kordie
Dennis Kordie is a Family healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1447640362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dennis Kordie has received a total of $1,512 in payments from pharmaceutical and medical device companies, with $701.60 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,512).
As a Medicare-enrolled provider, Kordie has provided services to 709 Medicare beneficiaries, totaling 1,625 services with total Medicare billing of $115,495. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family
- Location East Orange, NJ
- Active Since 01/30/2015
- Last Updated 01/07/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447640362
Products in Payments
- VRAYLAR (Drug) $369.31
- XARELTO (Drug) $240.79
- AMPLATZER AMULET (Device) $141.97
- FANAPT (Drug) $125.00
- VIVITROL (Drug) $110.45
- TEFLARO (Drug) $83.06
- ELIQUIS (Drug) $79.00
- DIFICID (Drug) $78.55
- CAMZYOS (Drug) $58.51
- LOKELMA (Drug) $13.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in East Orange
Lilian Kordie
Family — Payments: $1,167
Primerose Germain, Fnp-Bc, FNP-BC
Family — Payments: $624.49
Mrs. Neida Jimenez, Apn, APN
Family — Payments: $617.40
Marie Tunis-Blanc, Apn, APN
Family — Payments: $395.27
Karol Pineiro, Msn, Fnp-Bc, MSN, FNP-BC
Family — Payments: $300.12
Mrs. Bernadette Galli, Apn, APN
Family — Payments: $217.00